Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Sylvester who wrote (2831)	7/24/1999 3:53:00 PM
From: Jacques Chitte	Read Replies (1) \| Respond to of 4140

>The analyst from Kinnard, was informed, well spoken, but completely wrong about their being too many players.< He was also wrong (or coy!) about another thing - the statement that SNRS has no value to VISX. Visx would likely LOVE to have the SNRS technology because they are about to come under fire for the night vision issues. VISX procedure is surgery after all, and the loss-of-contrast is an inherent feature of Lasik. Having the non-surgical SNRS process would be like going from analog to digital, to steal a metaphor from the cell phone biz.